Delaware Street Drug Report
October 2026 | Report #2026-16
Approved: October 28, 2026
Contact: ORC@delaware.gov
Disclaimer
This report is provided for educational and risk-mitigation purposes only. It is not intended for professional, clinical, legal, or publication use.
The data comes from limited drug residue testing conducted at various locations throughout Delaware. Results represent tested samples only and should not be assumed to reflect the entire drug supply.
Street drug stamp names are not standardized and may vary by location or supplier. The stamps listed below were collected from samples submitted during September 2026.
September 2026 Sample Results
Drug Stamps and Compounds Detected
| Sample Stamp | Compounds Detected |
|---|---|
| Cutwater | Fentanyl, Medetomidine |
| KFC | Cocaine |
| Newport | 4-ANPP, Fentanyl, Lidocaine, Medetomidine |
| Redlight | Fentanyl, Medetomidine, Procaine, Tetracaine |
| Super Sonic | 4-ANPP, Fentanyl, Mannitol, Medetomidine |
| Supersonic | 4-ANPP, Fentanyl, Medetomidine |
| Uber | Fentanyl, Medetomidine |
| Plastic Bag Sample 1 | 4-ANPP, Cocaine, Fentanyl, Medetomidine, Melatonin, Tetracaine |
| Plastic Bag Sample 2 | 4-ANPP, Cocaine, Fentanyl, Medetomidine, Tetracaine |
| Plastic Bag Sample 3 | 4-ANPP, 6-Monoacetylmorphine, Fentanyl, Lidocaine, Mannitol, Papaverine |
| Plastic Bag Sample 4 | 4-ANPP, Fentanyl, Medetomidine, Tetracaine |
| Used Device Sample 1 | 4-ANPP, Fentanyl, Medetomidine |
| Used Device Sample 2 | Cocaine, Phenacetin |
| Used Device Sample 3 | Methamphetamine, N,N-Dimethylamphetamine |
Substance Highlights
Cocaine
Cocaine is a stimulant classified as a Schedule II controlled substance by the U.S. Drug Enforcement Administration (DEA). It has a high potential for misuse and addiction.
Reported effects may include:
- Restlessness
- Paranoia
- Insomnia
- Loss of appetite
- Irregular heartbeat
- Seizures
Medetomidine
Medetomidine is a veterinary sedative that is not approved for human use. It is considered more potent than xylazine.
Reported adverse effects may include:
- Sedation
- Bradycardia (slow heart rate)
- Severe withdrawal symptoms
Substance Trends
Percentage of Tested Samples Containing Each Substance
Sample Counts by Month
| Month | Samples Tested |
|---|---|
| April 2026 | 42 |
| May 2026 | 64 |
| June 2026 | 137 |
| July 2026 | 72 |
| August 2026 | 174 |
| September 2026 | 74 |
Detection Rates
| Compound Detected | Apr 2026 | May 2026 | Jun 2026 | Jul 2026 | Aug 2026 | Sep 2026 |
|---|---|---|---|---|---|---|
| Xylazine | 2% | 5% | 1% | 0% | 0% | 0% |
| Medetomidine | 21% | 36% | 24% | 15% | 20% | 20% |
| Fentanyl | 71% | 42% | 23% | 19% | 22% | 18% |
| Tetracaine | 43% | 27% | 20% | 11% | 11% | 5% |
| Procaine | 45% | 11% | 7% | 3% | 6% | 1% |
| Lidocaine | 2% | 9% | 4% | 1% | 4% | 3% |
| 4-ANPP | 29% | 11% | 8% | 4% | 8% | 11% |
| BTMPS | 0% | 0% | 0% | 1% | 0% | 0% |
| Fluorofentanyl | 0% | 0% | 0% | 6% | 0% | 0% |
| Cocaine | 37% | 56% | 70% | 78% | 53% | 80% |
| Methamphetamine | 7% | 6% | 3% | 1% | 9% | 3% |
| Pregabalin | 0% | 0% | 0% | 0% | 0% | 0% |
| Heroin | 2% | 0% | 1% | 0% | 0% | 0% |
| Carfentanil | 0% | 0% | 0% | 0% | 0% | 0% |
| Quinine | 2% | 0% | 1% | 6% | 0% | 0% |
| Levamisole | 2% | 2% | 0% | 0% | 0% | 0% |
Key Findings
- The total number of samples tested was lower this month.
- A larger proportion of cocaine-positive samples contributed to an increase in the percentage of samples containing cocaine.
- Rates of medetomidine and fentanyl detections have stabilized compared with earlier months in 2026.
- Xylazine was not detected in any tested samples during September 2026, continuing a trend observed in previous months.
Alternative Text for Trend Chart
Figure: Monthly Substance Detection Trends (April through September 2026)
Line chart showing percentage of samples containing selected substances over six months. Cocaine increases from 37% in April to 80% in September, with fluctuations during the period. Medetomidine decreases after peaking at 36% in May and remains at 20% in September. Fentanyl decreases from 71% in April to 18% in September. Xylazine remains at very low levels and reaches 0% from July through September. Methamphetamine remains below 10% throughout the reporting period.